- Record: found
- Abstract: not found
- Article: not found
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer
David D. Yang ,
Brandon A. Mahal ,
Vinayak Muralidhar ,
Michelle D. Nezolosky ,
Marie E. Vastola ,
Shelby A. Labe ,
Ninjin Boldbaatar ,
Martin T. King ,
Neil E. Martin ,
Peter F. Orio ,
Clair J. Beard ,
Karen E. Hoffman ,
Quoc-Dien Trinh ,
Daniel E. Spratt ,
Felix Y. Feng ,
Paul L. Nguyen
June 2017
June 2017
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
It is unknown whether active surveillance can be safely offered to patients with Gleason
3+4 favorable intermediate-risk (FIR) prostate cancer.